Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity (Q43071609)
Jump to navigation
Jump to search
scientific article published on 5 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity |
scientific article published on 5 May 2010 |
Statements
1 reference
Six-month exenatide improves HOMA hyperbolic product in type 2 diabetic patients mostly by enhancing beta-cell function rather than insulin sensitivity (English)
1 reference
V Preumont
1 reference
M-P Hermans
1 reference
S Brichard
1 reference
M Buysschaert
1 reference
5 May 2010
1 reference
1 reference
Identifiers
1 reference